arXiv:2606.01051v1 Announce Type: new Abstract: Dynamic medical treatment requires deciding treatment intensity and intervention timing, while patient states evolve continuously and adverse events may occur between clinical interactions. Most existing treatment learning methods assume fixed schedules or enforce safety only at discrete decision points. We propose Interaction-Limited Safe Continuous-Time Reinforcement Learning, a framework that jointly optimizes treatment administration and clinical interaction timing under trajectory-level safety constraints. Our key idea is to reformulate the
The increasing sophistication of AI models and the demand for autonomous decision-making in critical fields like medicine drive the development of continuous-time reinforcement learning with safety guarantees.
This development moves AI beyond simple prediction to real-time, robust, and safe autonomous intervention in dynamic, high-stakes environments, directly impacting patient care and regulatory frameworks.
AI systems can now optimize complex sequential decision-making in continuous processes while actively managing safety, shifting from reactive to proactive, constrained action.
- · AI researchers in safe RL
- · Healthcare technology providers
- · Patients receiving dynamic treatments
- · Medical AI startups
- · Traditional drug development models
- · Healthcare providers resistant to AI integration
- · AI models lacking safety and robustness guarantees
More adaptive and personalized medical treatments become possible, guided by AI.
Regulatory bodies will need to establish new frameworks for the approval and deployment of autonomous AI medical interventions.
The success in medical applications could accelerate the adoption of similar continuous-time, safe AI in other critical infrastructure and complex systems.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG